| abstract |
The present invention provides novel indazole carboxamide 5-HT 4 receptor agonist compounds. The present invention also provides pharmaceutically acceptable compositions containing such compounds, methods of using such compounds to treat diseases associated with 5-HT 4 receptor activity, and such compounds. Processes and intermediates useful for the preparation are provided. In one embodiment, the compound of formula (I): , A pharmaceutically acceptable salt of the compound, a solvate of the compound, or a stereoisomer of the compound. |